Target intelligence / Profile preview

C2 domain-containing protein 2 (C2CD2)

Target
C2CD2
Molecular classification
Other (C2 domain–containing protein family; not classified as receptor, enzyme, transporter, or ion channel)
01

Overview

C2 domain-containing protein 2 (C2CD2) is a cytosolic and nuclear protein belonging to the C2 domain–containing family, with a still not well-defined molecular function[4][6]. C2CD2 and related proteins are involved in the regulation of lipid transport at membrane contact sites, notably at endoplasmic reticulum–plasma membrane junctions, contributing to calcium-dependent modulation of phosphoinositide signaling. This activity is critical for endocrine processes such as insulin secretion (characterized for its paralog TMEM24), and more broadly, for signal coordination in specialized cell types like pancreatic beta cells and neurons[1]. Genetic studies suggest its variants affect physical performance in aging (e.g., gait speed, grip strength) and it is implicated as a potential player in cancer biology through gene fusions and immune-related gene panels[1]. As of now, C2CD2 is not validated as a classical therapeutic target (receptor, enzyme, transporter, etc.), and there are no known drugs or mechanisms of action directly targeting this protein[1][3][4].

Other names
C2 calcium-dependent domain containing 2C21orf25C21orf258TMEM24LTransmembrane protein 24-likeDKFZP586F0422CU025_HUMAN
02

Biological functions

Lipid transport at membrane contact sitesRegulation of phosphoinositide signalingInvolved in insulin secretion (paralog TMEM24 studies)Potential coordination of cellular signaling at endoplasmic reticulum–plasma membrane junctionsPossible role in musculoskeletal function and physical performance
03

Disease associations

Cancer (notably breast cancer: found in fusion transcripts and immune prognostic gene panels)Aging-related phenotypes (gait speed, grip strength)Other (correlations with physical performance and potentially immune regulation)
04

Biomarkers

Proposed prognostic biomarker gene panels in cancer[1]

Beyond the preview

Go deeper on C2 domain-containing protein 2 (C2CD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C2 domain-containing protein 2 (C2CD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call